• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bt-DUX:一种针对接受下肢恶性骨肿瘤手术患者的健康相关生活质量主观测量方法的开发。

The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor.

作者信息

Bekkering W Peter, Vlieland Theodora P M Vliet, Koopman Hendrik M, Schaap Gerard R, Schreuder H W Bart, Beishuizen Auke, Tissing Wim J E, Hoogerbrugge Peter M, Anninga Jacob K, Taminiau Antonie H M

机构信息

Department of Physical Therapy, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Pediatr Blood Cancer. 2009 Sep;53(3):348-55. doi: 10.1002/pbc.22078.

DOI:10.1002/pbc.22078
PMID:19459200
Abstract

BACKGROUND

To examine the practical applicability, internal consistency, and validity of the Bt-DUX, a disease-specific Health Related Quality of Life (HRQoL) instrument. The Bt-Dux was developed to examine patients' individual values of their life after a malignant bone tumor of the lower extremity at four domains (cosmetic, social, emotional, and functional).

PROCEDURE

Patients were eligible for this cross-sectional, multicenter study if they underwent surgery for a malignant tumor of the leg in a period ranging between 12 and 60 months before the recruitment. Assessments included: Bt-DUX, Toronto Extremity Salvage Score (TESS) Short Form (SF)-36, TNO-AZL Questionnaire for Adult's Quality of Life (TAAQOL), and TNO-AZL Children's Quality of Life Questionnaire (TACQOL).

RESULTS

Seventy-two patients (35 male, 37 female), mean age 17 (SD 4) years were included. Limb sparing surgery took place in 32 patients and ablative surgery in 40 patients. The Bt-DUX was completed in less than 5 min and easy to comprehend. The mean Bt-DUX score was 69.8 (SD 15.5), with Cronbach's alpha being 0.92. Domain-total correlations ranged between 0.84 and 0.88 (P < 0.01). Correlations between Bt-DUX Total score and TESS, SF-36 Physical and Mental Component Summary scales and selected TACQOL and TAAQOL scores were statistically significant (P < 0.05), except for the social scale of the TACQOL. The Bt-DUX was able to discriminate between patients with higher and lower TESS scores (P < 0.05).

CONCLUSION

The Bt-DUX was found to be a practical and valid instrument. Its added value compared with existing HRQoL measures needs to be further established.

摘要

背景

为检验特定疾病的健康相关生活质量(HRQoL)工具——Bt-DUX的实际适用性、内部一致性和有效性。开发Bt-DUX是为了在四个领域(外观、社交、情感和功能)评估下肢恶性骨肿瘤患者对其生活的个人价值观。

程序

如果患者在招募前12至60个月期间接受了腿部恶性肿瘤手术,则符合这项横断面多中心研究的条件。评估包括:Bt-DUX、多伦多肢体挽救评分(TESS)简表(SF)-36、TNO-AZL成人生活质量问卷(TAAQOL)和TNO-AZL儿童生活质量问卷(TACQOL)。

结果

纳入72例患者(男性35例,女性37例),平均年龄17(标准差4)岁。32例患者接受了保肢手术,40例患者接受了截肢手术。Bt-DUX在不到5分钟内即可完成,且易于理解。Bt-DUX平均得分为69.8(标准差15.5),克朗巴哈系数为0.92。领域总分相关性在0.84至0.88之间(P<0.01)。Bt-DUX总分与TESS、SF-36身体和心理成分汇总量表以及选定的TACQOL和TAAQOL得分之间的相关性具有统计学意义(P<0.05),TACQOL的社交量表除外。Bt-DUX能够区分TESS得分较高和较低的患者(P<0.05)。

结论

发现Bt-DUX是一种实用且有效的工具。与现有HRQoL测量方法相比,其附加值有待进一步确定。

相似文献

1
The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor.Bt-DUX:一种针对接受下肢恶性骨肿瘤手术患者的健康相关生活质量主观测量方法的开发。
Pediatr Blood Cancer. 2009 Sep;53(3):348-55. doi: 10.1002/pbc.22078.
2
A prospective study on quality of life and functional outcome in children and adolescents after malignant bone tumor surgery.一项关于恶性骨肿瘤手术后儿童和青少年生活质量和功能结果的前瞻性研究。
Pediatr Blood Cancer. 2012 Jun;58(6):978-85. doi: 10.1002/pbc.23328. Epub 2011 Oct 11.
3
Quality of life in young patients after bone tumor surgery around the knee joint and comparison with healthy controls.膝关节周围骨肿瘤手术后年轻患者的生活质量及其与健康对照组的比较。
Pediatr Blood Cancer. 2010 May;54(5):738-45. doi: 10.1002/pbc.22439.
4
Translation and preliminary validation of the English version of the DUX questionnaire for lower extremity bone tumor patients (Bt-DUX): a disease-specific measure for quality of life.下肢骨肿瘤患者 DUX 问卷(Bt-DUX)的英文版本的翻译和初步验证:一种特定于疾病的生活质量衡量标准。
J Surg Oncol. 2013 Mar;107(4):353-9. doi: 10.1002/jso.23218. Epub 2012 Jul 17.
5
Health-related quality of life and coping strategies of children after treatment of a malignant bone tumor: a 5-year follow-up study.恶性骨肿瘤治疗后儿童的健康相关生活质量及应对策略:一项5年随访研究
Pediatr Blood Cancer. 2005 Oct 15;45(5):694-9. doi: 10.1002/pbc.20408.
6
Cross-Cultural Validation of the Italian Version of the Bt-DUX: A Subjective Measure of Health-Related Quality of Life in Patients Who Underwent Surgery for Lower Extremity Malignant Bone Tumour.Bt-DUX意大利语版本的跨文化验证:一种用于接受下肢恶性骨肿瘤手术患者健康相关生活质量的主观测量方法。
Cancers (Basel). 2020 Jul 23;12(8):2015. doi: 10.3390/cancers12082015.
7
Quality of life after bone sarcoma surgery around the knee: A long-term follow-up study.膝关节周围骨肉瘤手术后的生活质量:一项长期随访研究。
Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12603. Epub 2016 Nov 7.
8
Cultural adaptation, translation and validation of a functional outcome questionnaire (TESS) to Portuguese with application to patients with lower extremity osteosarcoma.一份功能结局问卷(TESS)的文化调适、翻译及葡萄牙语版验证,并应用于下肢骨肉瘤患者
Pediatr Blood Cancer. 2008 May;50(5):1039-42. doi: 10.1002/pbc.21392.
9
Health related quality of life in adolescent and young adult survivors of lower extremity bone tumors.青少年和年轻成年下肢骨肿瘤幸存者的健康相关生活质量。
Pediatr Blood Cancer. 2012 Feb;58(2):265-73. doi: 10.1002/pbc.23017. Epub 2011 Feb 11.
10
Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire.一种用于测量过敏性鼻炎患者健康相关生活质量的新西班牙语工具的开发与验证:ESPRINT问卷
Value Health. 2007 Nov-Dec;10(6):466-77. doi: 10.1111/j.1524-4733.2007.00202.x.

引用本文的文献

1
Shared decision making in primary malignant bone tumour surgery around the knee in children and young adults: protocol for a prospective study.儿童和青年膝关节周围原发性恶性骨肿瘤手术中的共同决策:一项前瞻性研究方案。
J Orthop Surg Res. 2024 Nov 2;19(1):714. doi: 10.1186/s13018-024-05192-y.
2
The Sarcoma Assessment Measure (SAM): Preliminary Psychometric Validation of a Novel Patient-Reported Outcome Measure.肉瘤评估量表(SAM):一种新型患者报告结局量表的初步心理测量学验证
Cancers (Basel). 2024 Mar 8;16(6):1096. doi: 10.3390/cancers16061096.
3
Exploring the Use of Pictorial Approaches in the Development of Paediatric Patient-Reported Outcome Instruments: A Systematic Review.
探索图片法在儿科患者报告结局测评工具开发中的应用:系统评价。
Pharmacoeconomics. 2024 Jun;42(Suppl 1):9-37. doi: 10.1007/s40273-024-01357-z. Epub 2024 Feb 13.
4
The DUX-25 after Twenty-Five Years: New Analyses and Reference Data.25年后的DUX-25:新的分析与参考数据
Children (Basel). 2022 Oct 17;9(10):1569. doi: 10.3390/children9101569.
5
What matters to children with lower limb deformities: an international qualitative study guiding the development of a new patient-reported outcome measure.下肢畸形患儿关注的要点:一项指导开发新的患者报告结局指标的国际定性研究
J Patient Rep Outcomes. 2021 Apr 1;5(1):30. doi: 10.1186/s41687-021-00299-w.
6
Cross-Cultural Validation of the Italian Version of the Bt-DUX: A Subjective Measure of Health-Related Quality of Life in Patients Who Underwent Surgery for Lower Extremity Malignant Bone Tumour.Bt-DUX意大利语版本的跨文化验证:一种用于接受下肢恶性骨肿瘤手术患者健康相关生活质量的主观测量方法。
Cancers (Basel). 2020 Jul 23;12(8):2015. doi: 10.3390/cancers12082015.
7
Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors.使用一种简单形式以促进肉瘤幸存者治疗长期后果方面的交流。
Clin Sarcoma Res. 2020 Jan 16;10:2. doi: 10.1186/s13569-019-0124-3. eCollection 2020.
8
Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer.对患有癌症的青少年和青年所面临的与健康相关的生活质量问题的系统评价。
Qual Life Res. 2017 Jul;26(7):1659-1672. doi: 10.1007/s11136-017-1520-x. Epub 2017 Mar 1.
9
Cross-cultural adaptation and validation of the Chinese version of Toronto Extremity Salvage Score for patients with extremity sarcoma.肢体肉瘤患者中文版多伦多肢体挽救评分的跨文化调适与验证
Springerplus. 2016 Jul 19;5(1):1118. doi: 10.1186/s40064-016-2818-9. eCollection 2016.